# Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke

> **NCT05175547** · PHASE3 · COMPLETED · sponsor: **ProMedica Health System** · enrollment: 80 (actual)

## Conditions studied

- Stroke, Acute
- Blood Pressure
- Mechanical Thrombectomy

## Interventions

- **DRUG:** Clevidipine

## Key facts

- **NCT ID:** NCT05175547
- **Lead sponsor:** ProMedica Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-30
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05175547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05175547, "Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05175547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*